Vaxart, Inc.
Vaxart is a clinical-stage biotechnology company developing oral recombinant pill vaccines based on an innovative delivery platform. They focus on generating mucosal and systemic immunity against common viral diseases. The company aims to transform global health by pioneering safe, effective, and accessible vaccine solutions.
Officiellt Register
AI Kvalitetsanalys
Förtroendepoäng Detaljer
Snabblänkar
Webbplats Höjdpunkter
🌟 Liknande Pålitliga Företag
Context Therapeutics Inc.
Context Therapeutics is dedicated to advancing the treatment of solid tumors through the development of next-generation T cell engaging (TCE) bispecific antibody therapies. Their innovative pipeline features clinical-stage bispecific therapeutics designed to harness the immune system for targeted cancer eradication. The company focuses on innovative immunotherapeutic solutions, transforming cancer care and improving outcomes for patients.
AGENUS INC
Agenus is a biotechnology company focused on developing and commercializing immuno-oncology therapies. Their key products include botensilimab and balstilimab, which are in clinical trials for various cancers. The company is positioned as an innovator in the development of next-generation immunotherapies.
Evaxion A/S
Evaxion utilizes its AI-Immunology™ platform to challenge and improve standardized treatments. In oncology, they create personalized therapies, tailoring treatment to the individual. For infectious diseases, they design next-generation vaccines to address unmet medical needs. Their AI platform accelerates vaccine target discovery, design, and development.